Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster

Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2014-03, Vol.118, p.79-86
Hauptverfasser: Alò, Raffaella, Avolio, Ennio, Mele, Maria, Storino, Francesca, Canonaco, Alessia, Carelli, Antonio, Canonaco, Marcello
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue
container_start_page 79
container_title Pharmacology, biochemistry and behavior
container_volume 118
creator Alò, Raffaella
Avolio, Ennio
Mele, Maria
Storino, Francesca
Canonaco, Alessia
Carelli, Antonio
Canonaco, Marcello
description Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors. •Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.
doi_str_mv 10.1016/j.pbb.2014.01.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500693487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305714000161</els_id><sourcerecordid>1500693487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVJaTbb_oBeio652BnZsi2TUwnbphDopT0LWRpnZ_HHRpJDFvLjo80mPfYwaATv-8A8jH0VkAsQ9dUu33ddXoCQOYgcoPnAVkI1ZVaJpjljK4BWZCVUzTm7CGEHALKom0_svJCyVqm2Ys-bJ0vRxNkfrmjaUkfHlePDQgN1npaRzz2PW-QWp-jNwM14uHdmMHxa7IBL4PcmYuBmipQ53HsMgR4x_V2aJ5qHQyTLQ3xN0fTK2poxRPSf2cfeDAG_vL1r9vfH5s_NbXb3--evm-93mS2rMmayKHusVS0tGFU5a21jwYGyraiVAgkOHYJ0WMim7doCi0qoStke-9JA5co1uzxx935-WDBEPVKwOAxmwnkJWlQAdVvKpG7NxClq_RyCx17vPY3GH7QAfZSudzpJ10fpGoRO0lPn2xt-6UZ0_xrvllPg-hTAdOQjodfBEk4WHXm0UbuZ_oN_AYHFlRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1500693487</pqid></control><display><type>article</type><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</creator><creatorcontrib>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</creatorcontrib><description>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors. •Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/j.pbb.2014.01.007</identifier><identifier>PMID: 24468014</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>6-Cyano-7-nitroquinoxaline-2,3-dione - administration &amp; dosage ; AMPAR ; Amygdala - drug effects ; Amygdala - physiopathology ; Animals ; Anxiety - drug therapy ; Anxiety - genetics ; Anxiety - physiopathology ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Central amygdala nucleus ; Cricetinae ; Depression - drug therapy ; Depression - genetics ; Depression - physiopathology ; Excitatory Amino Acid Antagonists - administration &amp; dosage ; Forced swim test ; GABA-A Receptor Agonists - administration &amp; dosage ; GABAAR ; Isoxazoles - administration &amp; dosage ; Male ; Mesocricetus ; Microinjections ; Receptors, AMPA - drug effects ; Receptors, AMPA - genetics ; Receptors, AMPA - physiology ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Stress, Physiological</subject><ispartof>Pharmacology, biochemistry and behavior, 2014-03, Vol.118, p.79-86</ispartof><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</citedby><cites>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091305714000161$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24468014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alò, Raffaella</creatorcontrib><creatorcontrib>Avolio, Ennio</creatorcontrib><creatorcontrib>Mele, Maria</creatorcontrib><creatorcontrib>Storino, Francesca</creatorcontrib><creatorcontrib>Canonaco, Alessia</creatorcontrib><creatorcontrib>Carelli, Antonio</creatorcontrib><creatorcontrib>Canonaco, Marcello</creatorcontrib><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors. •Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</description><subject>6-Cyano-7-nitroquinoxaline-2,3-dione - administration &amp; dosage</subject><subject>AMPAR</subject><subject>Amygdala - drug effects</subject><subject>Amygdala - physiopathology</subject><subject>Animals</subject><subject>Anxiety - drug therapy</subject><subject>Anxiety - genetics</subject><subject>Anxiety - physiopathology</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Central amygdala nucleus</subject><subject>Cricetinae</subject><subject>Depression - drug therapy</subject><subject>Depression - genetics</subject><subject>Depression - physiopathology</subject><subject>Excitatory Amino Acid Antagonists - administration &amp; dosage</subject><subject>Forced swim test</subject><subject>GABA-A Receptor Agonists - administration &amp; dosage</subject><subject>GABAAR</subject><subject>Isoxazoles - administration &amp; dosage</subject><subject>Male</subject><subject>Mesocricetus</subject><subject>Microinjections</subject><subject>Receptors, AMPA - drug effects</subject><subject>Receptors, AMPA - genetics</subject><subject>Receptors, AMPA - physiology</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Stress, Physiological</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVJaTbb_oBeio652BnZsi2TUwnbphDopT0LWRpnZ_HHRpJDFvLjo80mPfYwaATv-8A8jH0VkAsQ9dUu33ddXoCQOYgcoPnAVkI1ZVaJpjljK4BWZCVUzTm7CGEHALKom0_svJCyVqm2Ys-bJ0vRxNkfrmjaUkfHlePDQgN1npaRzz2PW-QWp-jNwM14uHdmMHxa7IBL4PcmYuBmipQ53HsMgR4x_V2aJ5qHQyTLQ3xN0fTK2poxRPSf2cfeDAG_vL1r9vfH5s_NbXb3--evm-93mS2rMmayKHusVS0tGFU5a21jwYGyraiVAgkOHYJ0WMim7doCi0qoStke-9JA5co1uzxx935-WDBEPVKwOAxmwnkJWlQAdVvKpG7NxClq_RyCx17vPY3GH7QAfZSudzpJ10fpGoRO0lPn2xt-6UZ0_xrvllPg-hTAdOQjodfBEk4WHXm0UbuZ_oN_AYHFlRs</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Alò, Raffaella</creator><creator>Avolio, Ennio</creator><creator>Mele, Maria</creator><creator>Storino, Francesca</creator><creator>Canonaco, Alessia</creator><creator>Carelli, Antonio</creator><creator>Canonaco, Marcello</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><author>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>6-Cyano-7-nitroquinoxaline-2,3-dione - administration &amp; dosage</topic><topic>AMPAR</topic><topic>Amygdala - drug effects</topic><topic>Amygdala - physiopathology</topic><topic>Animals</topic><topic>Anxiety - drug therapy</topic><topic>Anxiety - genetics</topic><topic>Anxiety - physiopathology</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Central amygdala nucleus</topic><topic>Cricetinae</topic><topic>Depression - drug therapy</topic><topic>Depression - genetics</topic><topic>Depression - physiopathology</topic><topic>Excitatory Amino Acid Antagonists - administration &amp; dosage</topic><topic>Forced swim test</topic><topic>GABA-A Receptor Agonists - administration &amp; dosage</topic><topic>GABAAR</topic><topic>Isoxazoles - administration &amp; dosage</topic><topic>Male</topic><topic>Mesocricetus</topic><topic>Microinjections</topic><topic>Receptors, AMPA - drug effects</topic><topic>Receptors, AMPA - genetics</topic><topic>Receptors, AMPA - physiology</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Stress, Physiological</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alò, Raffaella</creatorcontrib><creatorcontrib>Avolio, Ennio</creatorcontrib><creatorcontrib>Mele, Maria</creatorcontrib><creatorcontrib>Storino, Francesca</creatorcontrib><creatorcontrib>Canonaco, Alessia</creatorcontrib><creatorcontrib>Carelli, Antonio</creatorcontrib><creatorcontrib>Canonaco, Marcello</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alò, Raffaella</au><au>Avolio, Ennio</au><au>Mele, Maria</au><au>Storino, Francesca</au><au>Canonaco, Alessia</au><au>Carelli, Antonio</au><au>Canonaco, Marcello</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2014-03</date><risdate>2014</risdate><volume>118</volume><spage>79</spage><epage>86</epage><pages>79-86</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><abstract>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors. •Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24468014</pmid><doi>10.1016/j.pbb.2014.01.007</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2014-03, Vol.118, p.79-86
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_1500693487
source MEDLINE; Elsevier ScienceDirect Journals
subjects 6-Cyano-7-nitroquinoxaline-2,3-dione - administration & dosage
AMPAR
Amygdala - drug effects
Amygdala - physiopathology
Animals
Anxiety - drug therapy
Anxiety - genetics
Anxiety - physiopathology
Behavior, Animal - drug effects
Behavior, Animal - physiology
Central amygdala nucleus
Cricetinae
Depression - drug therapy
Depression - genetics
Depression - physiopathology
Excitatory Amino Acid Antagonists - administration & dosage
Forced swim test
GABA-A Receptor Agonists - administration & dosage
GABAAR
Isoxazoles - administration & dosage
Male
Mesocricetus
Microinjections
Receptors, AMPA - drug effects
Receptors, AMPA - genetics
Receptors, AMPA - physiology
RNA, Messenger - genetics
RNA, Messenger - metabolism
Stress, Physiological
title Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Excitatory/inhibitory%20equilibrium%20of%20the%20central%20amygdala%20nucleus%20gates%20anti-depressive%20and%20anxiolytic%20states%20in%20the%20hamster&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Al%C3%B2,%20Raffaella&rft.date=2014-03&rft.volume=118&rft.spage=79&rft.epage=86&rft.pages=79-86&rft.issn=0091-3057&rft.eissn=1873-5177&rft_id=info:doi/10.1016/j.pbb.2014.01.007&rft_dat=%3Cproquest_cross%3E1500693487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1500693487&rft_id=info:pmid/24468014&rft_els_id=S0091305714000161&rfr_iscdi=true